The market for Hormones in Dosage Except Contraceptives and Antibiotics in Uruguay, valued at 99.438 million USD in 2023, has exhibited fluctuations over the past decade. From a low in 2015, the market showcased a resurgence in 2016 and maintained growth momentum to peak in 2021. However, declines in 2022 followed by a slight recovery in 2023 marked its recent performance. Year-on-year, the market grew by 1.88% in 2023, with a last 5-year CAGR of 1.58%, indicating moderate growth stability amidst short-term volatility.
Future trends to watch for include:
- Innovations in hormone therapies.
- Regulatory impacts on pricing and accessibility.
- Adoption rates of such therapies as public health awareness increases.
- Potential economic fluctuations affecting market stability.
